The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by IKB Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Jordanovski, Darko ^a   Herwartz, Christine ^a   Pawlowski, Anna ^a   Taute, Stefanie ^a   Frommolt, Peter ^b,c   Steger, Gertrud ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; HYPOXIA INDUCIBLE FACTOR; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZNF395; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; DNA BINDING; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HYPOXIA; INNATE IMMUNITY; NEOPLASM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN MODIFICATION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION;

ANOXIA; BASE SEQUENCE; CELL LINE, TUMOR; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; IMMUNITY, INNATE; MOLECULAR SEQUENCE DATA; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEOLYSIS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84884508501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074911     Document Type: Article

References (64)

1. Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP, (2006) Differential gene expression identifies subgroups of renal cell carcinoma. J Lab Clin Med 147: 250-267. doi:10.1016/j.lab.2006.04.001. PubMed: 16697773.
2. Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, et al. (2004) Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor. Cancer Res 64: 5442-5448. PubMed: 15289353.
3. Dalgin GS, Holloway DT, Liou LS, DeLisi C, (2007) Identification and characterization of renal cell carcinoma gene markers. Cancer INFORM 3: 65-92. PubMed: 19455236.
4. Yabe H, Tsukahara T, Kawaguchi S, Wada T, Sato N, et al. (2008) Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis. Oncol Rep 19: 129-134. PubMed: 18097586.
5. Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, et al. (2009) Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLOS ONE 4: e5947. doi:10.1371/journal.pone.0005947. PubMed: 19536297.
6. Fardin P, Barla A, Mosci S, Rosasco L, Verri A, et al. (2010) A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer 9: 185. doi:10.1186/1476-4598-9-185. PubMed: 20624283.
7. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, et al. (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93: 1337-1343. doi:10.1093/jnci/93.17.1337. PubMed: 11535709.
8. Jiang Y, Zhang W, Kondo K, Klco JM, St Martin TB, et al. (2003) Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res 1: 453-462. PubMed: 12692265.
9. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, et al. (2006) Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215-15226. doi:10.1074/jbc.M511408200. PubMed: 16565084.
10. Keith B, Johnson RS, Simon MC, (2012) HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22.
11. Karin M, (2008) The IkappaB kinase- a bridge between inflammation and cancer. Cell Res 18: 334-342. doi:10.1038/cr.2008.30. PubMed: 18301380.
12. Chariot A, (2009) The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 19: 404-413. doi:10.1016/j.tcb.2009.05.006. PubMed: 19648011.
13. O'Neill LA, Bowie AG, (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364. doi:10.1038/nri2079. PubMed: 17457343.
14. Koong AC, Chen EY, Giaccia AJ, (1994) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 54: 1425-1430. PubMed: 8137243.
15. van Uden P, Kenneth NS, Rocha S, (2008) Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412: 477-484. doi:10.1042/BJ20080476. PubMed: 18393939.
16. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, et al. (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103: 18154-18159. doi:10.1073/pnas.0602235103. PubMed: 17114296.
17. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811. doi:10.1038/nature06905. PubMed: 18432192.
18. Nizet V, Johnson RS, (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9: 609-617. doi:10.1038/nri2607. PubMed: 19704417.
19. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237. doi:10.1016/S0092-8674(04)00302-2. PubMed: 15084260.
20. Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, et al. (2009) Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci U S A 106: 2629-2634. doi:10.1073/pnas.0812256106. PubMed: 19196987.
21. Boeckle S, Pfister H, Steger G, (2002) A new cellular factor recognizes E2 binding sites which mediate transcriptional repression by E2. Virology 293: 103-117. doi:10.1006/viro.2001.1231. PubMed: 11853404.
22. Tanaka K, Shouguchi-Miyata J, Miyamoto N, Ikeda J-E, (2004) Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington disease gene. J Biol Chem 279: 7275-7286. PubMed: 14625278.
23. Sichtig N, Silling S, Steger G, (2007) Papillomavirus binding factor (PBF) mediated inhibition of cell growth is regulated by 14-3-3 β. Arch Biochem Biophys 464: 90-99. doi:10.1016/j.abb.2007.04.017. PubMed: 17531190.
24. Tsukahara T, Kimura S, Ichimiya S, Torigoe T, Kawaguchi S, et al. (2009) Scythe/BAT3 regulates apoptotic cell death induced by papillomavirus binding factor in human osteosarcoma. Cancer Sci, 100: 47-53. PubMed: 19018758.
25. Sichtig N, Körfer N, Steger G, (2007) Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex. Arch Biochem Biophys 467: 67-75. doi:10.1016/j.abb.2007.08.015. PubMed: 17897615.
26. Jordanovski D, Koehler C, Steger G, (2012) ZNF395 (HDBP2/PBF) is a target gene of HIF1alpha. Huntington's Disease- Core Concepts and Current Advances. Intech.
27. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, et al. (1993) Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 53: 5328-5333. PubMed: 8221669.
28. Sundström C, Nilsson K, (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 565-577. doi:10.1002/ijc.2910170504. PubMed: 178611.
29. Müller A, Ritzkowsky A, Steger G, (2002) Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J Virol 76: 11042-11053. doi:10.1128/JVI.76.21.11042-11053.2002. PubMed: 12368347.
30. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, et al. (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76: 5532-5539. doi:10.1128/JVI.76.11.5532-5539.2002. PubMed: 11991981.
31. Lin R, Heylbroeck C, Pitha PM, Hiscott J, (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986-2996. PubMed: 9566918.
32. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866. doi:10.1126/science.278.5339.860. PubMed: 9346484.
33. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, et al. (1998) Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S A 95: 3537-3542. doi:10.1073/pnas.95.7.3537. PubMed: 9520401.
34. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4.2.249. PubMed: 12925520.
35. Hufbauer M, Lazić D, Akgül B, Brandsma JL, Pfister H, et al. (2010) Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 403: 128-136. doi:10.1016/j.virol.2010.04.013. PubMed: 20451232.
36. Rehtanz M, Schmidt H-M, Warthorst U, Steger G, (2004) Direct interaction between nucleosome assembly protein-1 and the papillomavirus E2 proteins involved in activation of transcription. Mol Cell Biol 24: 2153-2168. doi:10.1128/MCB.24.5.2153-2168.2004. PubMed: 14966293.
37. Kitamura A, Takahashi K, Okajima A, Kitamura N, (1994) Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem 224: 877-883. doi:10.1111/j.1432-1033.1994.00877.x. PubMed: 7925411.
38. Fensterl V, Sen GC, (2011) The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31: 71-78. doi:10.1089/jir.2010.0101. PubMed: 20950130.
39. Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, et al. (2003) BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem 278: 1450-1456. doi:10.1074/jbc.M209677200. PubMed: 12403772.
40. Blazkova H, von Schubert C, Mikule K, Schwab R, Angliker N, et al. (2007) The IKK inhibitor BMS-345541 affects multiple mitotic cell cycle transitions. Cell Cycle 6: 2531-2540. doi:10.4161/cc.6.20.4807. PubMed: 17704647.
41. Schödel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, et al. (2011) High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117: e207-e217. doi:10.1182/blood-2010-10-314427. PubMed: 21447827.
42. Hallen LC, Burki Y, Ebeling M, Broger C, Siegrist F, et al. (2007) Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J Interferon Cytokine Res 27: 675-680. doi:10.1089/jir.2007.0021. PubMed: 17784819.
43. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, et al. (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11: 997-1004. doi:10.1038/ni.1932. PubMed: 20890285.
44. Ludlow LE, Johnstone RW, Clarke CJ, (2005) The HIN-200 family: more than interferon-inducible genes? Exp Cell Res 308: 1-17. doi:10.1016/j.yexcr.2005.03.032. PubMed: 15896773.
45. Hertoghs KM, Moerland PD, van Stijn A, Remmerswaal EB, Yong SL, et al. (2010) Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 120: 4077-4090. doi:10.1172/JCI42758. PubMed: 20921622.
46. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2008) Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology 380: 124-135. doi:10.1016/j.virol.2008.06.039. PubMed: 18692859.
47. Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, et al. (2007) Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol 81: 3477-3486. doi:10.1128/JVI.01552-06. PubMed: 17251300.
48. Gariano GR, Dell'Oste V, Bronzini M, Gatti D, Luganini A, et al. (2012) The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLOS Pathog 8: e1002498. PubMed: 22291595.
49. Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, et al. (2010) Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLOS Pathog 6: e1000781. PubMed: 20195503.
50. Hoverter NP, Ting JH, Sundaresh S, Baldi P, Waterman ML, (2012) A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol Cell Biol 32: 3648-3662. doi:10.1128/MCB.06769-11. PubMed: 22778133.
51. Wallmen B, Schrempp M, Hecht A, (2012) Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/beta-catenin target gene expression. Nucleic Acids Res 40: 9455-9469. doi:10.1093/nar/gks690. PubMed: 22859735.
52. Atcha FA, Syed A, Wu B, Hoverter NP, Yokoyama NN, et al. (2007) A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol Cell Biol 27: 8352-8363. doi:10.1128/MCB.02132-06. PubMed: 17893322.
53. Chang HM, Paulson M, Holko M, Rice CM, Williams BR, et al. (2004) Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A 101: 9578-9583. doi:10.1073/pnas.0400567101. PubMed: 15210966.
54. Geiger K, Leiherer A, Muendlein A, Stark N, Geller-Rhomberg S, et al. (2011) Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLOS ONE 6: e26465. doi:10.1371/journal.pone.0026465. PubMed: 22039494.
55. Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, et al. (2010) Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 9: 133. doi:10.1186/1476-4598-9-133. PubMed: 20515450.
56. Hong SW, Yoo JW, Kang HS, Kim S, Lee DK, (2009) HIF-1alpha-dependent gene expression program during the nucleic acid-triggered antiviral innate immune responses. Mol Cells 27: 243-250. doi:10.1007/s10059-009-0030-2. PubMed: 19277508.
57. Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, et al. (2011) Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19: 484-497. doi:10.1016/j.ccr.2011.02.008. PubMed: 21481790.
58. Yang CK, Kim JH, Li H, Stallcup MR, (2006) Differential use of functional domains by coiled-coil coactivator in its synergistic coactivator function with beta-catenin or GRIP1. J Biol Chem 281: 3389-3397. PubMed: 16344550.
59. Stein U, Walther W, Arlt F, Schwabe H, Smith J, et al. (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15: 59-67. doi:10.1038/nm.1889. PubMed: 19098908.
60. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC, (2011) The interferon stimulated gene 54 promotes apoptosis. J Biol Chem 286: 7257-7266. doi:10.1074/jbc.M110.207068. PubMed: 21190939.
61. Kim SS, Ahn CH, Kang MR, Kim YR, Kim HS, et al. (2010) Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers. Pathology 42: 50-53. doi:10.3109/00313020903434421. PubMed: 20025480.
62. Chefetz I, Ben Amitai D, Browning S, Skorecki K, Adir N, et al. (2008) Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. J Invest Dermatol 128: 1423-1429. doi:10.1038/sj.jid.5701203. PubMed: 18094730.
63. Tsuji K, Yasui K, Gen Y, Endo M, Dohi O, et al. (2010) PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma. Cancer Genet Cytogenet 198: 118-125. doi:10.1016/j.cancergencyto.2010.01.004. PubMed: 20362226.
64. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. doi:10.1093/nar/29.9.e45. PubMed: 11328886.